| Carvedilol and nebivolol improve left ventricular systolic functions in patients with non-ischemic heart failure | Mustafa KARABACAK,Abdullah DOĞAN,Şenol TAYYAR,Mehmet ÖZAYDIN,Doğan ERDOĞAN | 271–276 |
| Platelet-to-lymphocyte ratio is a predictor of in-hospital mortality patients with acute coronary syndrome | MUSTAFA OYLUMLU,Abdulkadir YILDIZ,Muhammed OYLUMLU,Murat YÜKSEL,NİHAT POLAT,MEHMET ZİHNİ BİLİK,Abdurrahman AKYÜZ,Mesut AYDIN,HALİT ACET,Serdar SOYDİNÇ | 277–283 |
| The relationship between dipping-non-dipping arterial blood pressure pattern and frequency of restless leg syndrome with related factors | MEMNUNE SENA ULU,Ahmet AHSEN,Önder AKÇİ,Fatima YAMAN,Kasım DEMİR,Gökhan YAMAN,Şeref YÜKSEL,Gürsel ACARTÜRK | 284–288 |
| Effect of percutaneous mitral balloon valvuloplasty on right ventricular functions in mitral stenosis: Short- and mid-term results | SİNAN İNCİ,Mustafa Kemal EROL,EFTAL MURAT BAKIRCI,HİKMET HAMUR,HÜSNÜ DEĞİRMENCİ,HAKAN DUMAN,ŞULE KARAKELLEOĞLU | 289–296 |
| Markus Reinthaler, Sunil K. Aggarwal, Rodney De Palma, Ulf Landmesser 1, Georg Froehlich,Predictors of clinical outcome in transfemoral TAVI: Circumferential iliofemoral calcifications and manufacturer-derived recommendations | Markus REİNTHALER,Sunil K. AGGARWAL,Rodney De PALMA,Ulf LANDMESSER,Georg FROEHLİCH,John YAP,Pascal MEIER,Michael J. MULLEN | 297–305 |
| The protective effect of single dose tadalafil in contrast-induced nephropathy: An experimental study | Kerem ÖZBEK,Köksal CEYHAN,Fatih KOÇ,Erkan SÖĞÜT,Fatih ALTUNKAŞ,METİN KARAYAKALI,ATAÇ ÇELİK,HASAN KADI,R. Doğan KÖSEOĞLU,ORHAN ÖNALAN | 306–310 |
| Phosphodiesterase-5 inhibitors: Emerging nephroprotective drugs (Editorial Comment) | Zaid ABASSİ,Zaher ARMALY | 311–312 |
| Acute effects of ultrafiltration on aortic mechanical properties determined by measurement of pulse wave velocity and pulse propagation time in hemodialysis patients | Banu YILDIZ ŞAHİN,Alparslan ŞAHİN,Nazire ALADAĞ BAŞKURT,Gülgün ARSLAN,Hakan KAPTANOĞULLARI,İbrahim AKIN,MUSTAFA YILDIZ | 313–317 |
| Arterial function and cardiovascular risk in dialysis (Editorial Comment) | Biagio R Di IORİO,Lucia Di MİCCO | 318–319 |
| Acute effect of zoledronic acid infusion on atrial fibrillation development in patients with osteoporosis | Zeynep Demet İLGEZDİ,İLKNUR AKTAŞ,Fatma METİN DOĞAN,ALPER KEPEZ,FEYZA ÜNLÜ ÖZKAN,Ayşe Duygu ŞİLTE,Meryem KAYSIN YILMAZ,Tarik KIVRAK,AHMET ALTUĞ ÇİNÇİN,OKAN ERDOĞAN | 320–324 |
| Determinants of inpatient costs of angina pectoris, myocardial infarction, and heart failure in a university hospital setting in Turkey | Kaan SÖZMEN,Özlem PEKEL,Tuba Sevim YILMAZ,Ceyda ŞAHAN,Ali CEYLAN,Ercan GÜLER,Eren KORKMAZ,Belgin ÜNAL | 325–333 |
| Mechanical index | TANER ŞEN,Omaç TÜFEKÇİOĞLU,YAVUZER KOZA | 334–336 |
| Life-saving urgent intervention in a low-birth-weight newborn with obstructed supracardiac total anomalous pulmonary venous connection: Stenting the vertical vein | ALPER GÜZELTAŞ,İbrahim Cansaran TANIDIR,Taner KASAR | 337–339 |
| Stuck aortic valve treated by reteplase in a Bentall patient | ÖMER TANYELİ,YÜKSEL DERELİ,MEHMET AKİF DÜZENLİ,NİYAZİ GÖRMÜŞ | 339–340 |
| Trial design, statins, atrial fibrillation, and prevention: Four horsemen of the apocalypse | YAVUZER KOZA,ZİYA ŞİMŞEK,MUHAMMED HAKAN TAŞ,HÜSEYİN ŞENOCAK | 341–341 |
| Frequently occurring Torsades de pointes attacks in an old patient on solifenacin therapy and management strategy ( To the Editor,) | Namık ÖZMEN,ÖMER YİĞİNER,Haluk ÜN,Burhan BIÇAKÇI | 342–343 |
| Coronary artery embolization after left ventriculography: A rare cause of myocardial infarction (To the Editor,) | İrfan ŞAHİN,Hüsnü ATMACA,Diyar KÖPRÜLÜ,BARIŞ GÜNGÖR,İlhan İlker AVCI | 343–343 |
| Heart failure and ımportance of collaboration of professional organizations: The role of the heart failure association of the european society of cardiology and its committee on national heart failure societies | YÜKSEL ÇAVUŞOĞLU,Petar M. SEFEROVIC,Alexandre MEBAZAA | 344–345 |